Synaptic dysfunction and loss is the strongest pathological correlate of cognitive decline in Alzheimer's disease (AD) with increasing evidence implicating neuropathological tau protein in this process. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.